Abstract:One route has been employed to prepare dendritic-linear block copolymer modified superparamagnetic iron oxide nanoparticles (SPIONs), which consist of a Fe(3)O(4) magnetic nanoparticle core and a dendritic-linear block copolymer, the focal point polyamidoamine-type dendron-b-poly(2-dimethylaminoethyl methacrylate)-b-poly(N-isopropylacrylamide) (PAMAM-b-PDMAEMA-b-PNIPAM) shell by two-step atom transfer radical polymerization (ATRP). Firstly, Fe(3)O(4) nanoparticles were prepared by a high-temperature solution phase reaction in the presence of iron(III) acetylacetonate [Fe(acac)(3)], oleic acid and oleylamine. Then propargyl focal point PAMAM-type dendron (generation 2.0, denoted as propargyl-D(2.0)) with four carboxyl acid end groups as a cap displaced the oleic acid and oleylamine on the surfaces. Subsequently, an initiator for ATRP was introduced onto the propargyl-D(2.0)-modified Fe(3)O(4) nanoparticle surfaces via click chemistry with 2'-azidoethyl-2-bromoisobutylate (AEBIB). PDMAEMA and PNIPAM were grown gradually from nanoparticle surfaces using two-step copper-mediated ATRP. Finally, a crosslinking reaction between PDMAEMA block with 1,2-bis(2-iodoethoxy) ethane (BIEE) was used to stabilize the nanoparticles and reverse aggregation. The modified nanoparticles were subjected to detailed characterization using FT-IR, DLS, XRD and TGA. Magnetization measurements confirmed the characteristic superparamagnetic behavior of all magnetic nanoparticles under room temperature. In addition, doxorubicin (DOX) as an anticancer drug model was loaded into the dendritic-linear block copolymer shell of the modified nanoparticles, and subsequently the drug release was performed in phosphoric acid buffer solution (pH 7.4) at 25 degrees C or 37 degrees C. The results verify that dendritic-linear block copolymer-modified nanoparticles as a drug carrier possess thermosensitive drug release behaviors. Furthermore, a methyl tetrazolium (MTT) assay of DOX-loaded dendritic-linear block copolymer-modified nanoparticles against Hela cells was evaluated. The results show that the modified nanoparticles can be used for drug delivery.

Water-soluble dendritic-linear triblock copolymer-modified magnetic nanoparticles: Preparation, characterization and drug release properties

Preparation and Biological Characterization of Hollow Magnetic Fe3O4@C Nanoparticles As Drug Carriers with High Drug Loading Capability, Ph-Control Drug Release and MRI Properties

Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.

Novel core–shell magnetic nanoparticles for Taxol encapsulation in biodegradable and biocompatible block copolymers: Preparation, characterization and release properties

Drug-loaded and Superparamagnetic Iron Oxide Nanoparticle Surface-Embedded Amphiphilic Block Copolymer Micelles for Integrated Chemotherapeutic Drug Delivery and MR Imaging.

Preparation of A Novel Magnetic and Thermo-Responsive Composite and Its Application in Drug Release

Surface design and preparation of multi-functional magnetic nanoparticles for cancer cell targeting, therapy, and imaging

Preparation of Magnetite Nanoparticles Coated with an Amphiphilic Block Copolymer: A Potential Drug Carrier with a Core-Shell-Corona Structure for Hydrophobic Drug Delivery

Dendrimer functionalized water soluble magnetic iron oxide conjugates as dual imaging probe for tumor targeting and drug delivery

Amphiphilic starlike dextran wrapped superparamagnetic iron oxide nanoparticle clsuters as effective magnetic resonance imaging probes

Fe3O4@poly(2-hydroxyethyl methacrylate)-graft-poly(ε}-caprolactone) magnetic nanoparticles with branched brush polymeric shell

Effect of alkyl chain lengths on the assemblies of magnetic nanoparticles coated with multi-functional thiolactone-containing copolymer

Fe3O4@poly(2-hydroxyethyl methacrylate)-graft-poly(ɛ-caprolactone) magnetic nanoparticles with branched brush polymeric shell

SPIONs/DOX loaded polymer nanoparticles for MRI detection and efficient cell targeting drug delivery

Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release

POLY(L-GLUTAMIC ACID)DENDRON BASED Ph SENSITIVE DRUG CARRIER WITH MAGNETIC NANOPARTICLE CORE

Thermo and Ph Dual Responsive, Polymer Shell Coated, Magnetic Mesoporous Silica Nanoparticles for Controlled Drug Release

In vitro and in silico characteristics of doxorubicin-loaded four polymeric-based polysaccharides-modified super paramagnetic iron oxide nanoparticles for cancer chemotherapy and magnetic resonance imaging

Dextran-coated Superparamagnetic Nanoparticles As Potential Cancer Drug Carriers in Vivo.

Magnetic Drug Carrier with a Smart Ph-Responsive Polymer Network Shell for Controlled Delivery of Doxorubicin

Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent